TLDR: Key Points
- Elana Margulies-Snyderman interviews Chris Bostick and Thea Pham from OCV Partners about venture capital investing in technology and health care startups.
- OCV Partners focuses on technology and health care startups and has a multidisciplinary team with diverse backgrounds.
In a recent interview with Elana Margulies-Snyderman, Chris Bostick and Thea Pham from OCV Partners discussed venture capital investing in technology and health care startups. OCV Partners, a Los Angeles-based venture capital firm, focuses on investing in startups in the technology and health care sectors. The team at OCV Partners has a diverse background with various skill sets and experiences, allowing them to bring a unique perspective to their investment decisions.
Chris Bostick highlighted the opportunities in the health care technology sector, emphasizing the need for innovation to address the industry’s outdated infrastructure. He discussed the challenges of investing in a market with misaligned incentives and the importance of creating products that benefit all stakeholders, including patients, providers, and payers.
Thea Pham shared insights into leveraging cutting-edge technologies like gen AI to improve processes in health care and drive innovation. OCV Partners aims to support founders who are using technology to revolutionize the health care industry and enhance patient care.
Additionally, the discussion touched on OCV Partners’ approach to environmental, social, and governance (ESG) and diversity, equity, and inclusion (DEI) topics. The firm is committed to supporting underrepresented founders and has invested in a significant number of companies led by individuals from diverse backgrounds.
Overall, OCV Partners is optimistic about the future of the market and looks forward to continuing to provide value to their portfolio companies and investors as they launch their next fund.